HomeCompareIBXNF vs EPRT

IBXNF vs EPRT: Dividend Comparison 2026

IBXNF yields 200.00% · EPRT yields 3.97%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IBXNF wins by $119.30M in total portfolio value
10 years
IBXNF
IBXNF
● Live price
200.00%
Share price
$1.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$119.36M
Annual income
$60,176,096.29
Full IBXNF calculator →
EPRT
EPRT
● Live price
3.97%
Share price
$30.36
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$64.3K
Annual income
$13,170.85
Full EPRT calculator →

Portfolio growth — IBXNF vs EPRT

📍 IBXNF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIBXNFEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IBXNF + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IBXNF pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IBXNF
Annual income on $10K today (after 15% tax)
$17,000.00/yr
After 10yr DRIP, annual income (after tax)
$51,149,681.85/yr
EPRT
Annual income on $10K today (after 15% tax)
$337.37/yr
After 10yr DRIP, annual income (after tax)
$11,195.22/yr
At 15% tax rate, IBXNF beats the other by $51,138,486.62/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IBXNF + EPRT for your $10,000?

IBXNF: 50%EPRT: 50%
100% EPRT50/50100% IBXNF
Portfolio after 10yr
$59.71M
Annual income
$30,094,633.57/yr
Blended yield
50.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

IBXNF
No analyst data
Altman Z
5.4
Piotroski
6/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+16.9% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IBXNF buys
0
EPRT buys
0
No recent congressional trades found for IBXNF or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIBXNFEPRT
Forward yield200.00%3.97%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$119.36M$64.3K
Annual income after 10y$60,176,096.29$13,170.85
Total dividends collected$112.49M$38.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: IBXNF vs EPRT ($10,000, DRIP)

YearIBXNF PortfolioIBXNF Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$30,700$20,000.00$11,212$512.01+$19.5KIBXNF
2$90,232$57,383.18$12,689$692.09+$77.5KIBXNF
3$254,173$157,624.56$14,521$944.30+$239.7KIBXNF
4$686,927$414,961.74$16,841$1,302.88+$670.1KIBXNF
5$1,783,118$1,048,106.39$19,841$1,821.64+$1.76MIBXNF
6$4,450,613$2,542,677.12$23,818$2,587.47+$4.43MIBXNF
7$10,693,420$5,931,263.38$29,230$3,744.65+$10.66MIBXNF
8$24,760,608$13,318,648.86$36,816$5,540.38+$24.72MIBXNF
9$55,315,649$28,821,798.66$47,806$8,413.17+$55.27MIBXNF
10$119,363,841$60,176,096.29$64,324$13,170.85+$119.30MIBXNF

IBXNF vs EPRT: Complete Analysis 2026

IBXNFStock

IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, Germany, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; collagen ELISAs for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides lyophilization services for making disposable medical device components; and custom fermentation and contract manufacturing services. It serves manufacturers of medical devices, quality control labs, low molecular weight heparin manufacturers, and academic research institutions. IBEX Technologies Inc. was incorporated in 1972 and is based in Montreal, Canada.

Full IBXNF Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this IBXNF vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IBXNF vs SCHDIBXNF vs JEPIIBXNF vs OIBXNF vs KOIBXNF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.